Association of proline-directed protein kinase FA with tumorigenesis, invasion, and poor prognosis of human colon carcinoma

Cancer

Volumn 95, Issue 9, 2002, Pages 1840-1847

  Chung, Yuan Chiang ^a,b   Chang, King Jen ^c   Yang, Chuan Ching ^a   Lai, Ming Tsung ^a   Hsu, Chih Ping ^a   Hsueh, Sheng Feng ^a   Peng, Chien Chung ^a   Fu, Hsiao Hui ^a   Chang, Ya Fen ^b,c   Yang, Shiaw Der ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b Provincial Hsin Chu Hospital   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Colon carcinoma; Invasion; PDPK FA; Prognosis; Progression; Tumorigenesis

Indexed keywords

COMPLEMENTARY DNA; PROLINE; PROLINE DIRECTED PROTEIN KINASE FA; PROTEIN KINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CELL ADHESION; CELL CLONE; CHEMOTAXIS; CLINICAL FEATURE; COLON CARCINOMA; CONTROLLED STUDY; ENZYME LOCALIZATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CLONE CELLS; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR CELLS, CULTURED;

EID: 0036839664     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10904     Document Type: Article

References (35)

1. Bast RC Jr., Ravdin P, Hayes DF, et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1865-1878.
2. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP. American Joint Committee on Cancer prognostic factors consensus conference: Colorectal working group. Cancer. 2000;88:1739-1757.
3. Gennari L, Doci R, Rossetti C. Prognostic factors in colorectal cancer. Hepatogastroenterology. 2000;47:310-314.
4. Midgley R, Kerr D. Colorectal cancer. Lancet. 1999;353:391-399.
5. Bresalier RS, Ho SB. Molecular staging of colorectal cancer: A step forward. Gastroenterology. 1999;116:769-770.
6. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525-532.
7. A/GSK-3α (a proline-directed kinase and a regulator of protooncogenes) with human cervical carcinoma dedifferentiation/progression. J Cell Biochem. 1995;59:143-150.
8. A/GSK-3α (a proline-directed protein kinase) correlates with human hepatoma dedifferentiation/progression. J Cell Biochem. 1996;61:238-245.
9. A/GSK-3α correlates with human thyroid tumor cell dedifferentiation. J Cell Biochem. 1995;58:474-480.
10. A/GSK-3α in well- and poorly-differentiated human prostate carcinoma cells. J Protein Chem. 1998;17:329-335.
11. Hsu CP, Yang CC, Yang SD. Suppression of proline-directed protein kinase FA expression potentiates erythroid differentiation of human myeloid leukemia cell. Cancer. 2000;89:1004-1011.
12. A expression inhibits the growth of human chronic myeloid leukemia cells. Br J Cancer. 2000;82:1480-1484.
13. A systemically inhibits the growth of human acute leukemia cells. Int J Cancer. 2001;91:650-653.
14. A enhances chemosensitivity in human prostate cancer cells. Clin Cancer Res. 2000;6:1024-1030.
15. Cos S, Fernandez R, Guezmes A, Sanchez-Barcelo EJ. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 1998;58:4383-4390.
16. William CS, Tsujii M, Recse J, Dey SK, DuBiois RN. Host cycloxygenase-2 modulates carcinoma growth. J Clin Invest. 2000;105:1589-1594.
17. Bras-Goncalves RA, Rosty C, Laurent-Puig P, Soulie P, Dutrillaux B, Poupon MF. Sensitivity to CPT-11 of microsatellite instability and p53 status. Br J Cancer. 2000;82:913-923.
18. A/GSK-3α in NIH 3T3 cells by ethanol and cadmium. Proc Natl Sci Counc Repub China [B]. 1998;22:68-75.
19. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352-358.
20. Hart IR, Goode NT, Wilson RE. Molecular aspects of the metastatic cascade. Biochim Biophys Acta. 1989;989:65-84.
21. Hart IR, Saini A. Biology of tumour metastasis. Lancet. 1992;339:1453-1467.
22. Van Roy F, Mareel M. Tumour invasion: Effects of cell adhesion and motility. Trends Cell Biol. 1992;2:163-169.
23. Tang DG, Honn KV. Adhesion molecules and tumor metastasis: An update. Invasion Metastasis. 1994;14:109-122.
24. Jothy S, Munro SB, LeDuy L, McClure D, Blaschuk OW. Adhesion or anti-adhesion in cancer: What matters more? Cancer Metastasis Rev. 1995;14:363-376.
25. Nicolson GL. Organ specificity of tumor metastasis: Role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev. 1988;7:143-188.
26. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet. 1992;340:1053-1058.
27. Schumacher U, Higgs D, Loizidou M, Pickering R, Leathern A, Taylor I. Helix pomatia agglutinin binding is a useful prognostic indicator in colorectal carcinoma. Cancer. 1994;74:3104-3107.
28. Ruoslahti E. Fibronectin and its integrin receptors in cancer. Adv Cancer Res. 1999;76:1-20.
29. Deans GT, Parks TG, Rowlands BJ, Spence RAJ. Prognostic factors in colorectal cancer. Br J Surg. 1992;99:608-613.
30. Beahrs OH. Colorectal cancer staging as a prognostic feature. Cancer. 1982;50:2615-2617.
31. Fielding LP, Philips RKS, Fry JS, Hittinger R. Prediction of outcome after curative resection for large bowel cancer. Lancet. 1986;2:904-909.
32. Bouzourene H, Gervaz P, Cerottini JP, et al. p53 and Ki-ras as prognostic factors for Dukes stage B colorectal cancer. Eur J Cancer. 2000;36:1008-1015.
33. Wolmark N, Fisher B, Wieand S. The prognostic value of the modification of the Dukes C class of colorectal cancer. Ann Surg. 1986;203:115-121.
34. Srivastava S, Verma M, Henson DE. Biomarkers for early detection of colon cancer. Clin Cancer Res. 2001;7:1118-1126.
35. Fahy B, Bold RJ. Epidemiology and molecular genetics of colorectal cancer. Surg Oncol. 1998;7:115-123.